HC Wainwright reissued their buy rating on shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock. Several other brokerages have also recently commented on UNCY. Noble Financial started coverage on Unicycive Therapeutics in a research report on […]
Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 437.76% from the stock’s previous close. A number of […]
Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective points to a potential upside of 437.76% from the […]
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.